TipRanks
Akari Therapeutics (DE:CLA1)
FRANKFURT:CLA1

Compare Akari Therapeutics (CLA1) vs. Competitors

0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Akari Therapeutics
€0.06
€13.38M
>-0.01
-99.79%
3 Buy
0 Hold
0 Sell
Strong Buy
NanoViricides
$1.28
$32.67M
-3.11
-2.94%
1 Buy
0 Hold
0 Sell
Moderate Buy
Moleculin Biotech
$0.61
$8.44M
-0.02
-96.28%
3 Buy
0 Hold
0 Sell
Strong Buy
Passage Bio
$4.52
$14.64M
-0.40
-58.11%
0 Buy
1 Hold
0 Sell
Hold
SAB Biotherapeutics
$3.88
$257.49M
0.79
16.02%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:CLA1
Akari Therapeutics
0.06
-29.14
-99.79%
SONN
―
―
―
―
NNVC
NanoViricides
1.32
-0.03
-2.22%
MBRX
Moleculin Biotech
0.44
-11.94
-96.48%
PASG
Passage Bio
3.64
-4.87
-57.23%
SABS
SAB Biotherapeutics
2.68
0.38
16.52%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts